The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Drug Test Doubts Surround The World Cup

April 11, 2014 11:26 am | by JOHN LEICESTER, AP Sports Writer | News | Comments

FIFA's medical chief is "really not happy" with drug-testing plans for the World Cup in Brazil because samples taken from players must be flown across the Atlantic for analysis at a laboratory in Switzerland, which could slow results.       


Adamas Pharma Rises After IPO Raises $48M

April 11, 2014 11:22 am | by Associated Press | News | Comments

Shares of Adamas Pharmaceuticals rose Thursday after the drug developer's initial public offering raised $48 million.                                  


GranuFlo Lawsuits Continue As Fresenius Medical Care Announces NaturaLyte Recall In Canada

April 11, 2014 11:19 am | News | Comments

As GranuFlo lawsuits stemming from the 2012 recall of GranuFlo and NaturaLyte dialysis concentrates continue to move forward in the U.S., Bernstein Liebhard LLP notes that Fresenius Medical Care has announced a new NaturaLyte recall in Canada.


FDA Approves Lipiodol Injection For Tumor Imaging

April 11, 2014 11:12 am | News | Comments

Guerbet announced that Lipiodol® was approved by the US Food and Drug Administration pursuant to section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act indicated for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC). 


Let's Get The Zohydro Facts Straight

April 11, 2014 11:04 am | by Associated Press | News | Comments

Rampant misinformation about Zohydro ER continues to be reported by the media and echoed in Washington D.C. and some states' capitals. These inaccurate and misleading statements are often made without proper context, and are intended to be sensational, to create fear or to generate headlines.


Biotech Drops Again

April 11, 2014 10:58 am | by MATTHEW CRAFT, AP Business Writer | News | Comments

Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again started dumping shares of cutting-edge drug companies and other industries that have soared over the past year.


Medicaid Rules Reduce Narcotic Prescriptions

April 11, 2014 10:57 am | by BLAKE DAVIS, Associated Press | News | Comments

Maine's severe restrictions on opioid painkillers for Medicaid patients, requiring many to instead seek alternative pain management treatment for the past year, have sharply reduced the number of people obtaining highly addictive medications blamed for drug abuse and deaths around the nation.


High Performance Gate Valves

April 10, 2014 4:03 pm | by Nikita Ernst, Associate Editor | Product Releases | Comments

The Swivldisc Gate Valves are available in ½” through 4” sizes and feature a wedge gate design that employs a flexible disc.


Laser Diffraction Software

April 10, 2014 2:58 pm | by Nikita Ernst, Associate Editor | Malvern Instruments Inc. | Product Releases | Comments

A new software upgrade for the Mastersizer 3000 laser diffraction particle size analyzer continues to lighten the analytical workload associated with developing and validating robust particle sizing methods for pharmaceutical applications.

R&D Tablet Presses

April 10, 2014 2:52 pm | by Nikita Ernst, Associate Editor | Romaco, Inc. | Product Releases | Comments

The STYL’ONE series of R&D tablet presses allows for the automatic exploration of the tablet design space with practically no powder waste. 

Digital Watermarking For Folding Carton Packaging

April 10, 2014 2:36 pm | by Nikita Ernst, Associate Editor | Product Releases | Comments

Utilizing mobile technologies such as InvisiMarc™ (IM) code, the Digital Watermarks invisibly connect packages and other printed materials to interactive experiences on consumers’ smartphones.  

Some Expired Drugs are OK to Use

April 10, 2014 9:08 am | Videos | Comments

Report details when it's OK to use a drug that has expired and when it's not.                             

FDA Places Clinical Hold on Halozyme’s PEGPH20 Pancreatic Cancer Trial

April 10, 2014 8:58 am | News | Comments

Halozyme Therapeutics, Inc. has announced that the  FDA has  informed the company that a clinical hold has been placed on patient enrollment and dosing of PEGPH20 in an ongoing Phase 2 trial (Study 202) evaluating PEGPH20 in patients with pancreatic cancer.


Ranbaxy: Lessons and Opportunities

April 10, 2014 8:48 am | by Girish Malhotra, President, EPCOT International | Blogs | Comments

Will Sun’s latest acquisition change the global pharma landscape, or result in yet another problem-filled “me too” pharma company?                    


Saudi Arabia Reports Two More Deaths from MERS

April 10, 2014 8:38 am | by ADAM SCHRECK, Associated Press | News | Comments

Saudi health authorities said Wednesday that 11 people in the western city of Jiddah have contracted the Middle East respiratory syndrome, resulting in two recent deaths and prompting officials to temporarily shutter the emergency unit at one of the city's biggest hospitals.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.